Workflow
Ocugen (NasdaqCM:OCGN) 2025 Conference Transcript
OcugenOcugen(US:OCGN)2025-09-25 14:32

Ocugen (NasdaqCM:OCGN) 2025 Conference September 25, 2025 09:30 AM ET Company ParticipantsShankar Musunuri - CEO, Co-founder & Chairman of the BoardHuma Qamar - Chief Medical OfficerNoneWe're good to go. Okay. Good afternoon, and thanks for joining us to have a conversation with Shankar Moussunari, CEO, and Huma Kumar, CFO I mean, CMO of Ocugen. Ocugen is a biotech company focused on discovery, development, and commercializing novel gene and cell therapies. The company's proprietary gene therapy platform ha ...